Skip to content

NMA/AGSM/2022/BCS/009 - Reversal and Preventive Pleiotropic Mechanisms Involved in the Antipsychotic-Like Effect of Geraniol, Acyclic Isoprenoid Monoterpene in Ketamine-Induced Psychosis in Mice

C. Uruaka, O. Georgewill, OU Georgewill

Nigerian Medical Journal May 5, 2023

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled animal experiment Peer reviewed
Population Mice
Interventions Geraniol Risperidone Ketamine
Dose Geraniol 25, 50, and 100 mg/kg; risperidone 0.5 mg/kg; ketamine 20 mg/kg/day
Duration 14 consecutive days for preventive and reversal protocols
Measures Open-field test, social-interaction test, Y-maze test; brain levels of dopamine, serotonin, glutamic-acid decarboxylase, acetyl-cholinesterase, BDNF, glutathione, malondialdehyde, nitrite, TNF-α, IL-6, NFk-B
Topics Esketamine Ketamine
Key findings Geraniol (50-100 mg/kg) prevented and reversed ketamine-induced hyperlocomotion and social and cognitive deficits in mice, and at 100 mg/kg attenuated ketamine-induced dopaminergic, serotonergic, GABAergic, and cholinergic changes and reduced inflammatory and oxidative markers, similar to risperidone. The authors suggest geraniol has antipsychotic-like effects via neurochemical, neurotrophic, and oxido-inflammatory mechanisms.

Abstract

Background: Schizophrenia is a chronic neuropsychiatric disease characterized by neurochemical, neurotrophic, and oxido-inflammatory derangements. Geraniol is a neuroactive acyclic isoprenoid monoterpene, which has been reported to demonstrate depressant and antioxidant/anti-inflammatory activities. Herein, we investigated whether geraniol could prevent or reverse ketamine-induced schizophrenic-like behaviours and the underlying putative mechanisms in mice. Methodology In the preventive protocol, mice received intraperitoneal injections of geraniol (25, 50, and 100 mg/kg), risperidone (0.5 mg/kg), or saline daily for 14 consecutive days prior to ketamine (20 mg/kg/day, i.p.) from days 8-14. In the reversal protocol, the animals received ketamine or saline for 14 days prior to geraniol, risperidone, or saline treatments. Schizophrenic-like behaviors representing positive, negative, and cognitive symptoms were evaluated with open-field, social-interaction, and Y-maze tests. Thereafter, the brain levels of dopamine, serotonin, GABAergic (indexed by glutamic-acid decarboxylase), acetyl-cholinesterase, brain-derived neurotrophic factor (BDNF), oxidative//nitrergic stress (glutathione, malondialdehyde, nitrite), and inflammatory (TNF-α, IL-6, NFk-B) biomarkers were measured in the striatum, prefrontal cortex, and hippocampus.

Results: Geraniol (50-100 mg/kg) prevented and reversed ketamine-induced hyperlocomotion and social and cognitive deficits. Also, geraniol (100 mg/kg) attenuated ketamine-induced dopaminergic, serotonergic, GABAergic, and cholinergic neurotransmissions in brain region-dependent manners. The increased TNF-α, IL-6, NFk-B, and nitrite levels accompanied by decreased glutathione concentrations in the striatum, prefrontal cortex, and hippocampus in ketamine-treated mice were significantly prevented and reversed by geraniol like risperidone.

Conclusion: These findings suggest that geraniol exhibits an antipsychotic-like effect via attenuation of neurochemical, neurotrophic, and oxido-inflammatory changes in mice brains.

Comparable studies

Other preclinical and animal studies on ketamine, most cited first.

Explore topics